Cumberland Pharmaceuticals (CPIX) Market Capitalization (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Market Capitalization across 17 years of filings, most recently posting $97.1 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 93.73% year-over-year to $97.1 million; the TTM figure through Jun 2026 stood at $97.1 million (up 93.73% YoY), while the FY2025 annual figure was $59.5 million, up 80.02% from the prior year.
• Market Capitalization came in at $97.1 million for Q2 2026 at Cumberland Pharmaceuticals, up from $48.7 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $97.1 million in Q2 2026 to a low of $17.9 million in Q3 2024.
• Average Market Capitalization over 5 years is $39.0 million, with a median of $32.7 million recorded in 2022.
• Year-over-year, Market Capitalization tumbled 53.05% in 2022 and surged 166.03% in 2025.
• Over 5 years, Market Capitalization stood at $32.3 million in 2022, then retreated by 21.8% to $25.3 million in 2023, then jumped by 30.82% to $33.1 million in 2024, then surged by 80.02% to $59.5 million in 2025, then jumped by 63.1% to $97.1 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $97.1 million in Q2 2026, $48.7 million in Q1 2026, and $59.5 million in Q4 2025.